申通快遞(002468.SZ):申通投資擬對杭州溪鳥增資6285萬元
格隆匯8月19日丨申通快遞(002468.SZ)公佈,公司全資子公司申通投資管理(舟山)有限公司(簡稱“申通投資”)擬與浙江菜鳥供應鏈管理有限公司、浙江仲瑞投資管理有限公司、寧波梅山保税港區福杉投資有限公司及杭州溪鳥物流科技有限公司簽署《關於杭州溪鳥物流科技有限公司之增資協議的補充協議》,根據增資補充協議約定,申通投資此次對杭州溪鳥的增資金額為人民幣6285.00萬元,其中,人民幣125.70萬元計入杭州溪鳥的註冊資本,剩餘6159.30萬元計入杭州溪鳥的資本公積。此次交易完成後,申通投資在杭州溪鳥的持股比例由12.57%上升為13.95%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.